Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

366 Views

047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Treatment

(549) Ensitrelvir for the Treatment of COVID-19 Infection: Evaluation of Taste Disorder and Smell Disorder in the Phase 3 Part of the Phase 2/3 SCORPIO-SR Randomized Controlled Trial

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

YT

Yuko Tsuge, MSc

Shionogi
Osaka, Osaka, Japan

Co-Author(s)

TS

Takuhiro Sonoyama, MD

Senior Clinical
Shionogi & Co., Ltd.
Osaka, Osaka, Japan
HY

Hiroshi Yotsuyanagi, MD PhD

The University of Tokyo
Tokyo, Tokyo, Japan
NO

Norio Ohmagari, MD, MSc, PhD

Director
National Centre for Global Health and Medicine
Shinjuku, Tokyo, Japan
YD

Yohei Doi, MD, PhD

Professor of Medicine
Fujita Health University School of Medicine
Toyoake, Aichi, Japan
MY

Masaya Yamato, MD, PhD

Rinku General Medical Center
Izumisano, Osaka, Japan
TI

Takumi Imamura, M.Math

Shionogi
Osaka, Osaka, Japan
HM

Hiroshi Mukae, M.D., Ph.D.

Professor
Nagasaki University
Nagasaki, Nagasaki, Japan